Estro 2025 congress: ge healthcare to expand its radiation oncology portfolio and introduce new ai-enabled solutions

Chicago--(business wire)--ge healthcare (nasdaq: gehc) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new ai-enabled mr contour dl™ at the european society for therapeutic radiology and oncology (estro) 2025 congress in vienna, austria. the company will also showcase its updated intelligent radiation therapy (irt), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatmen.
GEHC Ratings Summary
GEHC Quant Ranking